1. Brady RO, Kanfer JN, Bradley RM, Shapiro D. Demonstration of a deficiency of glucocerebroside-cleaving enzyme in Gaucher's disease. J Clin Invest. 1966; 45:1112–5.
Article
2. Sidransky E. Gaucher disease: complexity in a “simple” disorder. Mol Genet Metab. 2004; 83:6–15.
Article
3. Futerman AH, van Meer G. The cell biology of lysosomal storage disorders. Nat Rev Mol Cell Biol. 2004; 5:554–65.
Article
4. Futerman AH, Zimran A. Gaucher disease. Boca Raton: CRC/ Taylor & Francis;2006. p. 175–96.
5. Wong K, Sidransky E, Verma A, et al. Neuropathology provides clues to the pathophysiology of Gaucher disease. Mol Genet Metab. 2004; 82:192–207.
Article
6. Ida H, Rennert OM, Kawame H, et al. Mutation screening of 17 Japanese patients with neuropathic Gaucher disease. Hum Genet. 1996; 98:167–71.
Article
7. Jeong SY, Park SJ, Kim HJ. Clinical and genetic characteristics of Korean patients with Gaucher disease. Blood Cells Mol Dis. 2011; 46:11–4.
Article
8. Kim HJ, Kang IJ, Kim HS, et al. Korean gaucher disease patient registry. Korean J Pediatr Hematol Oncol. 1998; 5:44–53.
9. Choi HS, Kim SH, Ida H, Kim HJ. The clinical characteristics and gene analysis of Korean Gaucher disease with central nervous abdominal involvement. J Korean Pediatr Soc. 2000; 43:611–8.
10. Goker-Alpan O, Schiffmann R, Park JK, et al. Phenotypic con-tinuum in neuronopathic gaucher disease: an intermediate phenotype between type 2 and type 3. J Pediatr. 2003; 143:273–6.
Article
11. Beutler E, Gelbart T, West C. Identification of six new Gaucher abdominal mutations. Genomics. 1993; 15:203–5.
12. Sinclair G, Choy FY, Ferreira P. Heterologous expression and abdominal of a rare Gaucher disease mutation (c.481C > T) from a Canadian aboriginal population using archival tissue samples. Mol Genet Metab. 2001; 74:345–52.
13. Yee RD, Purvin VA. Acquired ocular motor apraxia after aortic surgery. Trans Am Ophthalmol Soc. 2007; 105:152–8. discussion 158–9.
14. Leigh RJ, Zee DS. The neurology of eye movements. 4th ed.New York: Oxford University Press;2006. p. 108–87.
15. Harris CM, Taylor DS, Vellodi A. Ocular motor abnormalities in Gaucher disease. Neuropediatrics. 1999; 30:289–93.
Article
16. Gross-Tsur V, Har-Even Y, Gutman I, Amir N. Oculomotor abdominal: the presenting sign of Gaucher disease. Pediatr Neurol. 1989; 5:128–9.
17. Mignot C, Doummar D, Maire I, De Villemeur TB. Type 2 Gaucher disease: 15 new cases and review of the literature. Brain Dev. 2006; 28:39–48.
Article
18. Benko W, Ries M, Wiggs EA, et al. The saccadic and neurological deficits in type 3 Gaucher disease. PLoS One. 2011; 6:e22410.
Article
19. Yee RW. The effect of drop vehicle on the efficacy and side effects of topical glaucoma therapy: a review. Curr Opin Ophthalmol. 2007; 18:134–9.
Article
20. Beutler E, Grabowski GA. Gaucher Disease. Scriver CR, Sly WS, Childs B, editors. Metabolic and molecular bases of in-herited disease. 8th ed.Columbus: McGraw-Hill Inc;2001. 2.
21. Meivar-Levy I, Horowitz M, Futerman AH. Analysis of glucocere-brosidase activity using N-(1-[14C]hexanoyl)-D-erythroglucosyl-sphingosine demonstrates a correlation between levels of residual enzyme activity and the type of Gaucher disease. Biochem J. 1994; 303(Pt 2):377–82.
Article
22. Grabowski GA. Gaucher disease: gene frequencies and geno-type/phenotype correlations. Genet Test. 1997; 1:5–12.
Article
23. Hruska KS, LaMarca ME, Scott CR, Sidransky E. Gaucher abdominal: mutation and polymorphism spectrum in the glucocere-brosidase gene (GBA). Hum Mutat. 2008; 29:567–83.
24. Kawame H, Maekawa K, Eto Y. Molecular screening of Japanese patients with Gaucher disease: phenotypic variability in the same genotypes. Hum Mutat. 1993; 2:362–7.
Article
25. Eto Y, Ida H. Clinical and molecular characteristics of Japanese Gaucher disease. Neurochem Res. 1999; 24:207–11.
26. Zhao H, Keddache M, Bailey L, et al. Gaucher's disease: abdominal of novel mutant alleles and genotype-phenotype relationships. Clin Genet. 2003; 64:57–64.
27. Jmoudiak M, Futerman AH. Gaucher disease: pathological abdominal and modern management. Br J Haematol. 2005; 129:178–88.